Reply to Olanzapine/Risperidone and Diabetes Risk

Journal of Clinical Psychiatry - United States
doi 10.4088/jcp.v64n0718b
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Physicians Postgraduate Press, Inc

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy